Chris De Jonghe
Angel Investor @ PMV
Netherlands, United States
Chris De Jonghe is a Series A investor at PMV in Netherlands focused on Biotechnology and Medical. Chris De Jonghe - Member, Group Management Committee @ Vinnof
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Chris De Jonghe invests in
Stages Chris De Jonghe invests in
Countries Chris De Jonghe invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
- Manufacturing 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
Country
- Belgium 1 (33%)
- The Netherlands 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Immagene develops personalized cancer immunotherapies to fight multiple cancer type. | $21.4M / Series A / Apr 24, 2024 | ||
| Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models.They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugscurrently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept. | $14.6M / Series B / Jan 21, 2021 | ||
| Their Contract Research Organization (CRO) helps their clients assess the effects of their experimental Alzheimer treatments in their proprietary mouse models.They serve the majority of the Top 10 pharmaco’s worldwide with clients in the US, Europe and Japan. They have provided pivotal in-vivo proof-of-concept data for several candidate drugscurrently in clinical development, and work actively together with Dr. Sugimoto, the inventor of Aricept. | $13.7M / Series B / Dec 18, 2018 |
Co-Investors
About PMV
PMV is a do and dare company that is shaping the future of the Flemish economy.It provides funding for promising companies' businesses, from the day they first open their doors, through their various growth stages and even on to operating internationally.Working with and for the government and other partners, PMV implements projects thatare important for prosperity and well-being in Flanders.PMV is convinced that entrepreneurship is crucial for the development of a prosperous future for Flanders and everyone who lives there. It firmly believes that every promising enterprise project in Flanders needs to find funding – but also that every business needs to be profitable in order to be sustainable. Which is why PMV and the companies and projects in which it invests must be profitable in the end.
PMV Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Stefan De Waele
Senior Investment Manager
|
|||
Bart De Taeye
Investment Director
|
|||
Christine Claus
Director
|
|||
Clair Ysebaert
Director
|
|||
Diane Lejeune
Senior Investment Manager, Life Sciences and Care
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Chris De Jonghe invest in?
Chris De Jonghe invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Chris De Jonghe?
Public channels for Chris De Jonghe include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Chris De Jonghe last invest?
The most recent investment recorded for Chris De Jonghe closed in Apr 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
